News

Adding tools with graphic information to conversations about total knee replacement can improve patient understanding of the procedure’s benefits and risks, new research shows.

Synovitis is common in osteoarthritis, new research shows. The study suggests the need for a shift in treatment paradigms that target structural disease progression rather than just alleviating pain.

Drug-induced lupus and systemic lupus erythematosus (SLE) are two entirely different entities. Failure to identify SLE could lead to worsening symptoms, researchers say.

A new study published online ahead of print in Arthritis Care & Research sheds light on the barriers rheumatology patients face with regards to smoking cessation while describing individual reactions to cessation protocols and identifying patient centered outcomes after improvements in care.

Increased competition in the pharmaceutical market does not necessarily translate into price reductions. "Our findings illustrate a market failure contributing to the rising costs of prescription drugs," researchers write in JAMA Internal Medicine.

Enhancing supplementation of vitamin D among pregnant women could have far-reaching implications on the bone health of whole societies. That was the conclusion drawn from a study conducted in Iran on the impact of low-dose vitamin D supplements on fetal bone development.

The impact of omega-3 fatty acids (FA) on systemic inflammatory responses has been demonstrated in a number of dietary and epidemiologic studies. A recent editorial in Joint Bone Spine by Olfa Saidane1 and colleagues suggests a prophylactic role of Omega-3 FAs in the possible prevention of inflammatory diseases such as rheumatoid arthritis (RA).

Renal transplant can substantially improve survival rates for patients with lupus nephritis, according to new research.

A recent study published in Medicine highlights the top 100 articles focused on rheumatoid arthritis that have revealed the most data. Learn more in this article.

Using a frailty index to predict adverse outcomes and mortality in systemic lupus erythematosus proves to be feasible and effective in a study. The test, SLICC-FI, correlated well with existing measures of SLE disease activity, organ damage and HRQoL.

A recent study published in Arthritis & Rheumatology has demonstrated that belimumab is both safe and effective in patients with systemic lupus erythematosus and provides disease control over the long term.

A new set of treatment guidelines for Paget’s disease have been published leading with recommendations for the use of bisphosphonates.

A recent study suggests that the appearance of hidradenitis suppurativa may be another associated manifestation that can predict a more severe course of axial spondyloarthritis.

A recent study published in the Annals of the Rheumatic Diseases shows that ankylosing spondylitis is linked to an increased risk for venous thromboembolism and deep vein thrombosis.

Smoking in axial spondyloarthritis doesn't appear to impact treatment with TNF inhibitors despite the status of disease severity, a study shows.

Lack of trust in physicians, lack of information about biologics, medicine substitutions and the search for alternative therapies are among the reasons patients turn to the internet, a new study shows.

Historically, treatments for children with systemic juvenile idiopathic arthritis (sJIA) have been difficult and ineffective, leading to poor outcomes. But, findings from a new study point to a method that could lead to more positive results.

The therapy has been approved for use along with the One-Press injector—a device designed to fit comfortably in the patient’s hand and hide the needle through administration.

The 2018 American College of Rheumatology and the National Psoriasis Foundation released updated treatment guidelines for psoriatic arthritis (PsA). Test your knowledge of the current therapeutic recommendations for PsA in this quiz.

Higher lupus disease activity may be associated with bacteria from periodontal disease, which may be an important modifiable mediator of SLE disease activity.

The first liquid formulation of the common gout therapy is anticipated to improve instances of dosing adjustment for patients.

Patients who start out being diagnosed with seronegative arthritis probably won’t end up with seropositive rheumatoid arthritis (RA), researchers find.

Biological therapies prescribed for rheumatic diseases may also reduce their long-term risks of cardiovascular diseases (CVD), new research shows.

Patients can play a critical role in disseminating high quality healthcare, and rheumatology has been a trailblazer for giving them a voice in how they receive treatment, physicians write.

The JAK1 inhibitor will be considered as a marketed once-daily therapy for moderate to severe RA in the second half of this year.

A well-established treatment for psoriasis, psoriatic arthritis, and Crohn’s disease failed to work in axial spondyloarthritis patients, a study shows. But the study's failure may tell us more than not.

Total hip replacements are one of the most common and effective surgeries for women and men with osteoarthritis. The surgery can work miracles in patients, but the technology behind the surgery is not indestructible. At what point does failure set in?

A new study in JAMA Dermatology raises an interesting question for physicians who treat psoriasis patients. Does methotrexate work best in patients with plaque psoriasis alone or patients who have both psoriasis and arthritis?

In this quiz, we revisit recent advances made in systemic lupus erythematosus (SLE).

The benefits of exercise to combat the effects of musculoskeletal conditions have been well-documented. Take this quiz to test your knowledge of sports and exercise medicine in rheumatology.